SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Teva Reaffirms FY20 Guidance: EPS $2.30-$2.55, EBITDA $4.5B-$4.9B, Net Sales $16.6B-$17B

Benzinga · 05/07/2020 11:00